GNH USA

Europe — EMA

Nanohsa (Human Albumin Solution)

GNH USA supplies Nanohsa (Human Albumin), a plasma volume expander for hypovolemia and hypoalbuminemia. Request a quote for global supply.

Request sourcing

1
Pack/s

What is Human Albumin Solution?

Human Albumin, the active ingredient in Nanohsa, is a human albumin presented as a solution for injection for intradermal, intratumoral, and subcutaneous use. It is used to treat hypovolemia and hypoalbuminemia in patients requiring plasma volume expansion.

GNH USA supplies Nanohsa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

What is Human Albumin Solution used for?

Nanohsa (human albumin) is used as a plasma volume expander to manage conditions associated with low intravascular volume or albumin deficiency.

- Hypovolemia: restores circulating blood volume and improves tissue perfusion. - Hypoalbuminemia: raises serum albumin levels to maintain oncotic pressure. - Acute liver failure: supports plasma oncotic balance while awaiting liver support.

What are the side effects of Human Albumin Solution?

Human albumin may cause a range of adverse reactions, from mild to severe. Monitoring during and after administration is essential.

Common Side Effects: - Fever or chills - Mild hypotension - Headache - Nausea or vomiting

Serious or Rare Side Effects: - Anaphylactic reaction - Volume overload leading to pulmonary edema - Thromboembolic events - Hemolysis or severe hemolytic transfusion reaction

What precautions apply to Human Albumin Solution?

Human albumin should be administered with careful clinical assessment and monitoring.

- Assess volume status: evaluate fluid balance before infusion. - Monitor for allergic reactions: observe for rash, urticaria, or anaphylaxis. - Caution in heart failure: avoid excessive volume expansion. - Use cautiously in renal impairment: adjust volume as needed. - Do not exceed recommended volume: follow prescriber guidance. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Human Albumin Solution interact with?

Human albumin can interact with other therapies that affect fluid balance or coagulation.

Major Interactions (Avoid): - Concurrent use with other volume expanders may cause circulatory overload. - Co‑administration with high‑dose diuretics can precipitate severe hypovolemia. - Simultaneous infusion with blood products may increase risk of volume overload.

Moderate Interactions (Monitor Closely): - Anticoagulants: monitor coagulation parameters as albumin may alter plasma volume. - Nephrotoxic agents: adjust dosing to avoid renal stress. - Vasopressors: observe hemodynamic response during volume expansion.

Frequently asked questions

What is Nanohsa used for?+
Nanohsa contains human albumin and is used as a plasma volume expander to treat conditions such as hypovolemia and hypoalbuminemia, helping to restore intravascular volume and maintain oncotic pressure in patients who need fluid support.
How does human albumin work in Nanohsa?+
Human albumin increases plasma oncotic pressure, drawing water from the interstitial space into the bloodstream. This expands the circulating blood volume, improves tissue perfusion, and supports the transport of various substances throughout the body.
What is the usual dose of Nanohsa?+
The dose of Nanohsa is determined by the prescribing clinician based on the patient’s clinical condition, weight, and required volume expansion. The prescriber will calculate the appropriate volume to administer.
Is Nanohsa safe during pregnancy or breastfeeding?+
The safety of Nanohsa in pregnancy or while breastfeeding has not been definitively established. Clinicians should weigh potential benefits against possible risks and consider alternative therapies when appropriate.
How do I order Nanohsa from GNH USA?+
To order Nanohsa, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.
How does Nanohsa compare with other plasma expanders?+
Nanohsa provides natural human albumin, which offers oncotic support and binding capacity not present in synthetic colloids. Compared with crystalloids, albumin expands plasma volume more efficiently with less total fluid required, but it is generally more expensive and requires careful monitoring for volume overload.
What are the storage and handling requirements for Nanohsa?+
Nanohsa should be stored at 2‑8 °C in a refrigerator, protected from light. Do not freeze or shake the solution. Keep the vial in its original packaging until use to maintain sterility and stability.
How is Nanohsa administered?+
Nanohsa is supplied as a sterile solution for injection and can be given via intradermal, intratumoral, or subcutaneous routes, depending on the clinical indication. Administration is performed by qualified healthcare professionals under aseptic conditions.
What are the most serious risks associated with Nanohsa?+
Serious risks include anaphylactic reactions, volume overload leading to pulmonary edema, and thromboembolic events. Patients should be closely monitored for signs of respiratory distress, sudden hypotension, or unexpected swelling during and after infusion.
Who should not use Nanohsa?+
Nanohsa should be avoided in patients with known hypersensitivity to human albumin, uncontrolled heart failure, severe renal impairment where fluid overload is a concern, or in those where volume expansion could exacerbate existing conditions.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Human Albumin Solution
Route
Intradermal Use , Intratumoral Use , Subcutaneous
Manufacturer
Rotop Pharmaka Gmbh
Origin
EU

Related products